Latest Sandu Pharmaceuticals stock price

Sandu Pharmaceuticals P/E Ratio

SANDUPHQ • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
21.88
Moderate Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 21.88
Current Price ₹35.00
EPS (TTM) ₹1.60
Exchange BSE

Valuation Signal

Signal Overvalued
Historical Avg 38.78
Historical Range 17.3 - 59.22
Percentile 33.3%

Sector Context

Sector Average 48.14
Sector Median 27.02
Sector Rank #11 of 140
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹3.08
Mar 2025 ₹0.34
Sept 2024 ₹1.95

Key P/E Ratio Insights for Sandu Pharmaceuticals

  • Current PE is 43.6% below historical average
  • Trading at discount to sector average PE of 48.14

View the SANDUPHQ equity price for detailed stock performance.

P/E Ratio Historical Trend for Sandu Pharmaceuticals

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 17.3 3.31 ₹57.26 BSE Moderate
2023 59.22 1.15 ₹68.10 BSE High
2022 39.82 1.68 ₹66.90 BSE High

Sector P/E Ratio Comparison

Comparing Sandu Pharmaceuticals with other companies in Healthcare sector
Sector Average
48.14
Sector Median
27.02
Lowest P/E
1.14
Highest P/E
756.2
Companies
140
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.14 ₹40 Low
Murae Organisor MURAE 3.14 ₹45 Low
Ind Swift Laboratories INDSWFTLAB 4.83 ₹1,219 Low
Amwill Health Care AMWILL 6.5 ₹70 Low
Medicamen Organics MEDIORG 6.86 ₹28 Low
JFL Life Sciences JFLLIFE 7.19 ₹36 Low
Galaxy Medicare GML 7.86 ₹26 Low
Unichem Laboratories UNICHEMLAB 8.51 ₹2,497 Low
Zenith Drugs ZENITHDRUG 8.7 ₹87 Low
Brooks Laboratories BROOKS 9.37 ₹204 Low